CLOs on the Move

C. R. Bard

www.crbard.com

 
C. R. Bard is a leading multinational developer, manufacturer, and marketer of innovative, life-enhancing medical technologies in the fields of Vascular, Urology, Oncology, and Surgical Specialties. Bard markets its products and services worldwide to hospitals, individual health care professionals, extended care facilities, and alternate site facilities. Bard pioneered the development of single-patient-use medical products for hospital procedures; today Bard is dedicated to pursuing technological innovations that offer superior clinical benefits while helping to reduce overall health care costs.
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion
  • www.crbard.com
  • 730 Central Ave
    New Providence, NJ USA 07974
  • Phone: 908.277.8000

Executives

Name Title Contact Details
Samrat Khichi
Senior Vice President - General Counsel - Secretary Profile
Candace Camarata
Assistant General Counsel - Litigation Profile
Anthony Colesanti
Assistant General Counsel at Davol - A Bard Company Profile
Ann Hurtado
General Counsel Profile
Adam Rappaport
Assistant General Counsel Profile

Similar Companies

Healthline Systems Inc

Healthline Systems Inc is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

www.biosig.com

BioSig Technologies, Inc. (NASDAQ: BSGM) is a medical device company that is developing a proprietary biomedical signal processing technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Los Angeles-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP™System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig aims to deliver technology to improve upon catheter ablation treatments for the prevalent and potentially deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP™ System is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and has received FDA 510(k) clearance for the PURE EP™ System in August 2018. BioSig Technologies, Inc. is a Nasdaq company: NASDAQ:BSGM.

Fortec Medical

The ForTec Laser Rental Program provides medical lasers to hospitals, surgical centers and physicians delivering the latest in therapies and treatments.

Citagenix Inc

Citagenix Inc is a Laval, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

WelchAllyn

WelchAllyn is a Beaverton, OR-based company in the Healthcare, Pharmaceuticals, & Biotech sector.